Identifying potential survival strategies of HIV-1 through virus-host protein interaction networks

le van Dijk, David, Ertaylan, Gokhan, Boucher, Charles AB, Sloot, Peter MA
Foilsithe 2010

Extracting causal relations on HIV drug resistance from literature

le Bui, Quoc-Chinh, Nualláin, Breanndán Ó, Boucher, Charles A, Sloot, Peter MA
Foilsithe 2010

Worldwide Evaluation of DNA Sequencing Approaches for Identification of Drug Resistance Mutations in the Human Immunodeficiency Virus Type 1 Reverse Transcriptase

le Schuurman, Rob, Demeter, Lisa, Reichelderfer, Patricia, Tijnagel, Jolanda, de Groot, Tom, Boucher, Charles
Foilsithe 1999

The xenotropic murine leukemia virus-related retrovirus debate continues at first international workshop

le Stoye, Jonathan P, Silverman, Robert H, Boucher, Charles A, Le Grice, Stuart FJ
Foilsithe 2010

Letter to the editor: Pre-exposure prophylaxis for HIV in Europe: The need for resistance surveillance

le van Tienen, Carla, van de Vijver, David, Noori, Teymur, Sönnerborg, Anders, Boucher, Charles
Foilsithe in Euro Surveill (2017)

Stochastic processes strongly influence HIV-1 evolution during suboptimal protease-inhibitor therapy

le Nijhuis, Monique, Boucher, Charles A. B., Schipper, Pauline, Leitner, Thomas, Schuurman, Rob, Albert, Jan
Foilsithe 1998

Estimating Relative Fitness in Viral Competition Experiments

le Marée, Athanasius F. M., Keulen, Wilco, Boucher, Charles A. B., De Boer, Rob J.
Foilsithe 2000

Evolution of Lamivudine Resistance in Human Immunodeficiency Virus Type 1-Infected Individuals: the Relative Roles of Drift and Selection

le Frost, Simon D. W., Nijhuis, Monique, Schuurman, Rob, Boucher, Charles A. B., Brown, Andrew J. Leigh
Foilsithe 2000

Regional Challenges in the Prevention of Human Immunodeficiency Virus Drug Resistance

le Godfrey, Catherine, Bobkova, Marina, Boucher, Charles, Ravasi, Giovanni, Chen, Ping, Zhang, Fujie, Wu, Yasong, Kantor, Rami
Foilsithe in J Infect Dis (2017)

Criteria for Drugs Used in Pre-Exposure Prophylaxis Trials against HIV Infection

le Derdelinckx, Inge, Wainberg, Mark A, Lange, Joep M. A, Hill, Andrew, Halima, Yasmin, Boucher, Charles A. B
Foilsithe 2006

Five years of monitoring for the emergence of oseltamivir resistance in patients with influenza A infections in the Influenza Resistance Information Study

le Lina, Bruno, Boucher, Charles, Osterhaus, Albert, Monto, Arnold S., Schutten, Martin, Whitley, Richard J., Nguyen‐Van‐Tam, Jonathan S.
Foilsithe in Influenza Other Respir Viruses (2018)

Targeted HCV core antigen monitoring among HIV-positive men who have sex with men is cost-saving

le Popping, Stephanie, Nichols, Brooke, Rijnders, Bart, van Kampen, Jeroen, Verbon, Annelies, Boucher, Charles, van de Vijver, David
Foilsithe in J Virus Erad (2019)

Identification of a novel resistance (E40F) and compensatory (K43E) substitution in HIV-1 reverse transcriptase

le Huigen, Marleen CDG, van Ham, Petronella M, de Graaf, Loek, Kagan, Ron M, Boucher, Charles AB, Nijhuis, Monique
Foilsithe 2008

The need for a European hepatitis C programme monitoring resistance to direct-acting antiviral agents in real life to eliminate hepatitis C

le Popping, Stephanie, Cento, Valeria, García, Federico, Ceccherini-Silberstein, Francesca, Seguin-Devaux, Carole, Vijver, David AMC, Boucher, Charles A
Foilsithe in J Virus Erad (2018)

Report from the International Viral Hepatitis Elimination Meeting (IVHEM), 17–18 November 2017, Amsterdam, the Netherlands: gaps and challenges in the WHO 2030 hepatitis C eliminat...

le Popping, Stephanie, El-Sayed, Manal, Feld, Jordan, Hatzakis, Angelos, Hellard, Margaret, Lesi, Olufunmilayo, Ninburg, Michael, Ward, John, Boucher, Charles
Foilsithe in J Virus Erad (2018)

Zika Virus: Where Is the Treatment?

le Mumtaz, Noreen, van Kampen, Jeroen J. A., Reusken, Chantal B. E. M., Boucher, Charles A. B., Koopmans, Marion P. G.
Foilsithe in Curr Treat Options Infect Dis (2016)

Epidemiological impact and cost‐effectiveness of providing long‐acting pre‐exposure prophylaxis to injectable contraceptive users for HIV prevention in South Africa: a modelling st...

le van Vliet, Marjolein M, Hendrickson, Cheryl, Nichols, Brooke E, Boucher, Charles AB, Peters, Remco PH, van de Vijver, David AMC
Foilsithe in J Int AIDS Soc (2019)

Modulation of HIV-1 Gag NC/p1 cleavage efficiency affects protease inhibitor resistance and viral replicative capacity

le van Maarseveen, Noortje M, Andersson, Dan, Lepšík, Martin, Fun, Axel, Schipper, Pauline J, de Jong, Dorien, Boucher, Charles AB, Nijhuis, Monique
Foilsithe 2012

Diminished transmission of drug resistant HIV-1 variants with reduced replication capacity in a human transmission model

le Pingen, Marieke, Sarrami-Forooshani, Ramin, Wensing, Annemarie MJ, van Ham, Petra, Drewniak, Agata, Boucher, Charles AB, Geijtenbeek, Teunis BH, Nijhuis, Monique
Foilsithe in Retrovirology (2014)

Genotypic Changes in Human Immunodeficiency Virus Type 1 Protease Associated with Reduced Susceptibility and Virologic Response to the Protease Inhibitor Tipranavir

le Baxter, John D., Schapiro, Jonathan M., Boucher, Charles A. B., Kohlbrenner, Veronika M., Hall, David B., Scherer, Joseph R., Mayers, Douglas L.
Foilsithe 2006